Ancylostomiasis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 9: | Line 9: | ||
[[Anti-helminthic]] [[therapies]] are recommended among [[patients]] with [[ancylostomiasis]].<ref name="pmid27929101">{{cite journal| author=Loukas A, Hotez PJ, Diemert D, Yazdanbakhsh M, McCarthy JS, Correa-Oliveira R | display-authors=etal| title=Hookworm infection. | journal=Nat Rev Dis Primers | year= 2016 | volume= 2 | issue= | pages= 16088 | pmid=27929101 | doi=10.1038/nrdp.2016.88 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27929101 }} </ref> | [[Anti-helminthic]] [[therapies]] are recommended among [[patients]] with [[ancylostomiasis]].<ref name="pmid27929101">{{cite journal| author=Loukas A, Hotez PJ, Diemert D, Yazdanbakhsh M, McCarthy JS, Correa-Oliveira R | display-authors=etal| title=Hookworm infection. | journal=Nat Rev Dis Primers | year= 2016 | volume= 2 | issue= | pages= 16088 | pmid=27929101 | doi=10.1038/nrdp.2016.88 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27929101 }} </ref> | ||
For stable uncomplicated cases | *'''For stable uncomplicated cases''' | ||
**'''Adult''' | |||
***Preferred regimen: Albendazole 400 mg PO single dose | |||
*Preferred regimen: Albendazole 400 mg PO single dose | ***Alternative regimen: Mebendazole 100 mg PO q12h for 3 days | ||
*Alternative regimen: Mebendazole 100 mg PO q12h for 3 days | ***Alternative regimen: Pyrantel Pamoate 11mg/kg PO q24h for 3 days (maximum, 1gm per dose) | ||
*Alternative regimen: Pyrantel Pamoate 11mg/kg PO q24h for 3 days (maximum, 1gm per dose) | |||
==References== | ==References== |
Revision as of 09:11, 19 August 2021
Ancylostomiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ancylostomiasis medical therapy On the Web |
American Roentgen Ray Society Images of Ancylostomiasis medical therapy |
Risk calculators and risk factors for Ancylostomiasis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Anti-helminthic therapies are recommended among patients with ancylostomiasis.[1]
- For stable uncomplicated cases
- Adult
- Preferred regimen: Albendazole 400 mg PO single dose
- Alternative regimen: Mebendazole 100 mg PO q12h for 3 days
- Alternative regimen: Pyrantel Pamoate 11mg/kg PO q24h for 3 days (maximum, 1gm per dose)
- Adult
References
- ↑ Loukas A, Hotez PJ, Diemert D, Yazdanbakhsh M, McCarthy JS, Correa-Oliveira R; et al. (2016). "Hookworm infection". Nat Rev Dis Primers. 2: 16088. doi:10.1038/nrdp.2016.88. PMID 27929101.